N🟁N

VIVUS to Present at J.P. Morgan 2008 SMid Cap Conference

  //health-fitness.news-articles.net/content/2008/ .. sent-at-j-p-morgan-2008-smid-cap-conference.html
  Published in Health and Fitness on Tuesday, December 2nd 2008 at 5:26 GMT by Market Wire
          ^{🞛 This publication is a summary or evaluation of another publication}

MOUNTAIN VIEW, Calif.--([ BUSINESS WIRE ])--VIVUS, Inc. (NASDAQ: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced that Timothy Morris, vice president and CFO, will present at the J.P. Morgan SMid Cap Conference in New York. The two-day conference will feature presentations from more than 80 small and mid-cap companies across all sectors.

The VIVUS presentation will take place on Friday December 5, 2008 at 1:30 p.m. ET. A live audio webcast and 14-day archive of the presentation will be available at [ http://ir.vivus.com ].

About VIVUS

VIVUS, Inc. is a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products. The current portfolio includes investigational products addressing obesity, diabetes and sexual health. The pipeline includes: Qnexa™, which is in phase 3 for the treatment of obesity and phase 2 for the treatment of type 2 diabetes; Testosterone MDTS®, for which a phase 2 study has been completed for the treatment of Hypoactive Sexual Desire Disorder (HSDD); and avanafil, for which a phase 2 study has been completed for the treatment of erectile dysfunction (ED). For more information on clinical trials and products, please visit the company's web site at [ http://www.vivus.com ].